149
Views
18
CrossRef citations to date
0
Altmetric
Original Articles

Total lesion glycolysis as an IgG4-related disease activity marker

, , , , , , , , , , , , & show all
Pages 579-584 | Received 07 Aug 2014, Accepted 19 Nov 2014, Published online: 30 Dec 2014
 

Abstract

Objectives. 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography (FDG-PET/CT) was reported to be useful for monitoring immunoglobulin G4-related disease (IgG4-RD); however, a quantitative FDG-PET/CT analysis such as total lesion glycolysis (TLG) has not yet been conducted. This study aimed to investigate whether TLG would correlate with serum markers in IgG4-RD, and the utility of TLG for disease monitoring.

Methods. This retrospective study included 17 patients (12 men; median age, 62 years) who were followed up at Kyoto University Hospital and underwent FDG-PET/CT from April 2009 to November 2013. TLG was calculated for the involved lesions. Correlations between serum markers [IgG4, soluble IL-2 receptor (sIL-2R), lactate dehydrogenase (LDH), and C-reactive protein (CRP)] and TLG concomitant with FDG-PET/CT scans were investigated. Serial changes in TLG were assessed in patients who underwent follow-up FDG-PET/CT (n = 6).

Results. The calculated median (IQL) TLG value was 154.8 (63.7–324.4). A significant correlation was found between the sIL-2R level and TLG (P = 0.001, rs = 0.763). In contrast, no correlations were found between the IgG4, LDH, or CRP levels and TLG. Increased or decreased TLG corresponded with clinical disease improvement or worsening.

Conclusions. TLG correlated significantly with the serum sIL-2R level and may be useful for disease monitoring in IgG4-RD.

Acknowledgments

We thank Drs. Y. Imura, M. Hashimoto, R. Nakashima, N. Yukawa, T. Nojima, D. Kawabata, T. Usui, K. Ohmura, and T. Fujii (Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University) for their contributions to clinical practice.

Conflict of interest

The authors declare no conflict of interests. This study was supported by grants from the respiratory failure research group and the IgG4-related disease research group of the Ministry of Health, Labour and Welfare, Japan. The funding source did not have any role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.

Supplementary material available online

Supplementary Figures 1, 2 and Table 1.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.